Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toos Daemen

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Vaccines|October 14, 2020
Therapeutic Vaccines and Cancer ImmunotherapyDarshak Bhatt, Toos Daemen
International Journal of Molecular Sciences|May 11, 2024
Molecular Circuits of Immune Sensing and Response to Oncolytic VirotherapyDarshak K Bhatt, Toos Daemen
Vaccines|October 26, 2021
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic AnalysisDarshak K Bhatt, Roger Chammas, Toos Daemen
Clinical & Developmental Immunology|December 23, 2011
From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsOana Draghiciu, Hans W Nijman, Toos Daemen
Immunology Letters|May 5, 2024
Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapiesAna Vizcaino Castro, Toos Daemen, Cesar Oyarce
Vaccines|September 8, 2015
Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte EpitopesPeng Peng Ip, Hans W Nijman, Toos Daemen
Methods in Enzymology|January 13, 2004
Influenza virosomes in vaccine developmentAnke Huckriede, Laura Bungener, Toos Daemen, et al.
Bioscience Reports|November 14, 2002
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMsLaura Bungener, Anke Huckriede, Jan Wilschut, et al.
International Journal of Cancer|April 25, 2022
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinomaShipeng Chen, Yuzhen Gao, Ying Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
HPV-specific immunotherapy: key role for immunomodulatorsStephanie Van de Wall, Hans W Nijman, Toos Daemen
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Vaccines|October 14, 2020
Therapeutic Vaccines and Cancer ImmunotherapyDarshak Bhatt, Toos Daemen
International Journal of Molecular Sciences|May 11, 2024
Molecular Circuits of Immune Sensing and Response to Oncolytic VirotherapyDarshak K Bhatt, Toos Daemen
Vaccines|October 26, 2021
Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic AnalysisDarshak K Bhatt, Roger Chammas, Toos Daemen
Clinical & Developmental Immunology|December 23, 2011
From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsOana Draghiciu, Hans W Nijman, Toos Daemen
Immunology Letters|May 5, 2024
Strategies to reprogram anti-inflammatory macrophages towards pro-inflammatory macrophages to support cancer immunotherapiesAna Vizcaino Castro, Toos Daemen, Cesar Oyarce
Vaccines|September 8, 2015
Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte EpitopesPeng Peng Ip, Hans W Nijman, Toos Daemen
Methods in Enzymology|January 13, 2004
Influenza virosomes in vaccine developmentAnke Huckriede, Laura Bungener, Toos Daemen, et al.
Bioscience Reports|November 14, 2002
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMsLaura Bungener, Anke Huckriede, Jan Wilschut, et al.
International Journal of Cancer|April 25, 2022
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus-related hepatocellular carcinomaShipeng Chen, Yuzhen Gao, Ying Wang, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
HPV-specific immunotherapy: key role for immunomodulatorsStephanie Van de Wall, Hans W Nijman, Toos Daemen
Pageof 9